Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00272545
Status:
COMPLETED
Last Update Posted:
2013-09-06
First Post:
2006-01-04
Brief Title:
Effectiveness of a Normalization of Eating Intervention Program for Treating Women With Eating Disorders
Sponsor:
Drexel University
Organization:
Drexel University
Study Overview
Official Title:
Adaptation of a CBT Intervention for Eating Disorders
Status:
COMPLETED
Status Verified Date:
2013-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the effectiveness of a new approach to a normalization of eating program based on principles of cognitive-behavioral therapy in treating women with anorexia nervosa or bulimia nervosa
Detailed Description:
Eating disorders are real treatable medical illnesses They are often characterized by disturbances in eating behavior such as drastic reduction of food intake or extreme overeating as well as feelings of distress or extreme concern about body shape or weight The two main types of eating disorders are anorexia nervosa and bulimia nervosa A third type binge-eating disorder is pending approval as a formal psychiatric diagnosis Eating disorders frequently develop during adolescence or early adulthood and they occur more often in females than in males Studies have shown cognitive behavioral therapy CBT to be the most effective approach to treating eating disorders However the applicability of these findings to clinical settings and intensive outpatient therapy programs IOPs remains unknown This study will evaluate the effectiveness of a new approach to a normalization of eating NOE program based on principles of CBT in treating women with anorexia nervosa or bulimia nervosa
Participants in this open-label study will be assigned to receive either treatment-as-usual TAU or NOE Participants admitted to the study in the first 8 months of the trial will receive TAU Those admitted after the first 8 months will take part in the NOE program Participants may begin receiving treatment as soon as they enter the study and will continue receiving their assigned treatments for 6 weeks All participants in the NOE group will be required to report to the study site three evenings a week They will receive individual therapy as well as take part in group and family therapy sessions In addition they will be supervised while eating a meal Body weight results of the Eating Disorders Examination and the Structured Clinical Interview for DSM-IV Axis I disorders and self-report measures will be assessed post-treatment and at the Month 6 follow-up visit
Note Participants are recruited from the Renfrew Centers outpatient programs located in the Philadelphia area Individuals outside of Renfrew cannot volunteer for this study For more information about the Renfrew Centers inpatient or outpatient treatment programs please call 1-800-RENFREW
Participants in this open-label study will be assigned to receive either treatment-as-usual TAU or NOE Participants admitted to the study in the first 8 months of the trial will receive TAU Those admitted after the first 8 months will take part in the NOE program Participants may begin receiving treatment as soon as they enter the study and will continue receiving their assigned treatments for 6 weeks All participants in the NOE group will be required to report to the study site three evenings a week They will receive individual therapy as well as take part in group and family therapy sessions In addition they will be supervised while eating a meal Body weight results of the Eating Disorders Examination and the Structured Clinical Interview for DSM-IV Axis I disorders and self-report measures will be assessed post-treatment and at the Month 6 follow-up visit
Note Participants are recruited from the Renfrew Centers outpatient programs located in the Philadelphia area Individuals outside of Renfrew cannot volunteer for this study For more information about the Renfrew Centers inpatient or outpatient treatment programs please call 1-800-RENFREW
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R34MH071691 | NIH | None | None |
| DATR A2-AIR | US NIH GrantContract | None | httpsreporternihgovquickSearchR34MH071691 |